Alzheimer’s Therapy Market Opportunities, Business Forecast To 2030
The report "Alzheimer’s Therapy Market by Drug Class (Cholinesterase Inhibitors, N-Methyl D-Aspartate Antagonist, Combination Drugs, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)) - Global Forecasts to 2030" The global Alzheimer’s Therapy Market is projected to reach USD 4,211.8 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 16.3% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=656727 Competitive Dashboard: The prominent key players operating in the global Alzheimer’s Therapy Market are Eisai Co., Ltd. Novartis AG. AbbVie Inc. Adamas Pharmaceuticals, Inc. H. Lundbeck A/S. Biogen. AC Immune. Cyclo Therapeutics Inc. F. Hoffmann La Roche Ltd. Daiichi Sankyo Company, Limited. Johnson & Johnson Services, Inc. TauRx Pharmaceuticals Ltd. Regional Overview: The report also examines the current concerns and their Fut...